Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Aeglea begins dosing in Phase I/II trial of AEB1102 for arginase 1 deficiency

Go Top